INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

78,781 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
9,167 sh
Mar 19, 2026Mar 20, 2026
Page 1299 of 1970
← PrevNext →
traded Mar 19, 2026
+1d
SEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
21.2K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SR
Stewart John REVP - Chief Financial Officer
HBNCHORIZON BANCORP INC /IN/
Tax withholding
F$10K
643 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
176.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
211.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
125.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
HJ
Hyman JonathanChief Technology Officer
BRZEBraze, Inc.
Grant or award
A—
89.6K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
487.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
30.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
9,167 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
375.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
NG
Nixon D. GailSenior VP, Human Resources
NNBRNN INC
Tax withholding
F$1,849
1,249 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
WS
Wiseman SusanGeneral Counsel
BRZEBraze, Inc.
Grant or award
A—
34.6K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
693.8K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
9,167 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
562.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
440.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
NG
Nixon D. GailSenior VP, Human Resources
NNBRNN INC
Option exercise
M—
123.5K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
440.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Grant or award
A—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PS
Plaines StephanieDirector
COTYCOTY INC.
Grant or award
A—
7,142 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
60.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
CC
Champlin Christopher CraigSenior Vice President, Sales
EIGEmployers Holdings, Inc.
Tax withholding
F$12K
306 sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AS
Aulestia Bernadette S.Director
NXSTNEXSTAR MEDIA GROUP, INC.
Grant or award
A—
905 sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
BH
Brown HaydenDirector, President & CEO
UPWKUPWORK, INC
Option exercise
M—
28.7K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
40.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AM
AmundiDirector, 10% Owner
VCTRVictory Capital Holdings, Inc.
Grant or award
A—
100.0K sh
Mar 18, 2026Mar 20, 2026
traded Mar 18, 2026
+2dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
20.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
DS
dMY Squared Sponsor, LLCDirector, 10% Owner
DMYYdMY Squared Technology Group, Inc.
Derivative conversion
C—
1.16M sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
20.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
PC
Peterson CarynEVP, Regulatory Affairs
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
126.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
157.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
GB
Giraudo BryanCOO/CFO
GOSSGossamer Bio, Inc.
Grant or award
A—
47.7K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
AR
Aranda RichardChief Medical Officer
GOSSGossamer Bio, Inc.
Grant or award
A—
572.0K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence

9
SP
Smith Robert Paul JRChief Commercial Officer
GOSSGossamer Bio, Inc.
Disposition to issuer
D—
562.5K sh
Mar 19, 2026Mar 20, 2026
traded Mar 19, 2026
+1dSEC Form 4

Evidence